Pulmonary Embolism

Study shows use of enoxaparin safe and effective, and cuts hospital stays

Published in Blood Weekly, January 16th, 2003

Researchers at Brigham and Women's Hospital (BWH) announced the results of a study showing that 90 days of treatment with the blood thinner enoxaparin for acute pulmonary embolism (PE) is as safe and effective as the standard treatment, unfractionated heparin (UFH) as a bridge to warfarin, and resulted in a shorter hospital stay.

The study was presented at the American Heart Association's scientific sessions 2002 in Chicago.

"Standard therapy with warfarin is cumbersome and requires monitoring of drug and food interactions with frequent blood testing, which can be avoided with enoxaparin," said leading investigator Joshua A. Beckman, MD, director of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2003-01-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry